Target intelligence / Profile preview

ITPK1 antisense RNA 1 (ITPK1-AS1)

Target
ITPK1-AS1
Molecular classification
Long non-coding RNA (lncRNA), Antisense RNA
01

Overview

ITPK1 antisense RNA 1 (ITPK1-AS1) is a long non-coding antisense RNA gene located on chromosome 14. It does not encode a protein but regulates gene expression at the RNA level, functioning primarily through post-transcriptional interactions with microRNAs as a competing endogenous RNA, thereby influencing cellular processes such as inflammation, cell proliferation, and signaling pathways. ITPK1-AS1 has been implicated as a biomarker and putative regulatory element in disorders associated with inflammation and acute ischemic stroke and may be part of disease-related signaling networks (e.g., PI3K/Akt, JAK/STAT). However, no approved drugs directly target ITPK1-AS1, and its precise molecular mechanism remains an active area of research.

Other names
C14orf85ITPK1-ASITPK1ASNCRNA00203ITPK1 antisense RNA (non-protein coding)ITPK1 antisense RNA 1 (non-protein coding)
02

Mechanism of action

Acts as a ceRNA to regulate target gene expression by sponging microRNAs (e.g., let-7 family)

03

Biological functions

Competing endogenous RNA (ceRNA) activity, regulating expression of target protein-coding genes via interaction with microRNAsMay influence immune response and inflammationPossible involvement in cell signaling pathways (e.g., PI3K/Akt, JAK/STAT)
04

Disease associations

Acute ischemic stroke (AIS)Inflammatory diseaseCancer (potential role indicated in some bioinformatic screens)
05

Biomarkers

Potential biomarker for diagnosis and prognosis of AIS and other inflammatory diseases

Beyond the preview

Go deeper on ITPK1 antisense RNA 1 (ITPK1-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ITPK1 antisense RNA 1 (ITPK1-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call